...
首页> 外文期刊>Alcohol and alcoholism: international journal of the Medical Council on Alcoholism >SUPPRESSING EFFECT OF THE CANNABINOID CB1 RECEPTOR ANTAGONIST, SR147778, ON ALCOHOL INTAKE AND MOTIVATIONAL PROPERTIES OF ALCOHOL IN ALCOHOL-PREFERRING sP RATS.
【24h】

SUPPRESSING EFFECT OF THE CANNABINOID CB1 RECEPTOR ANTAGONIST, SR147778, ON ALCOHOL INTAKE AND MOTIVATIONAL PROPERTIES OF ALCOHOL IN ALCOHOL-PREFERRING sP RATS.

机译:大麻素CB1受体拮抗剂SR147778对嗜醇sP大鼠的醇摄入和运动特性的抑制作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

AIMS: The present study investigated the effect of the newly synthesized cannabinoid CB(1) receptor antagonist, SR147778, on alcohol intake and the motivational properties of alcohol in selectively bred Sardinian alcohol-preferring (sP) rats. METHODS AND RESULTS: In Experiment 1, the repeated administration of SR147778 (0.3-3 mg/kg twice daily, i.p.) specifically suppressed the acquisition of alcohol drinking behaviour in alcohol-naive rats exposed to the two-bottle 'alcohol vs water' choice regimen for 24 h/day. In Experiment 2, an acute administration of SR147778 (2.5-10 mg/kg, i.p.) specifically reduced alcohol intake in alcohol-experienced rats that were given alcohol and water under the two-bottle choice regimen in daily sessions of 4 h. In Experiment 3, an acute administration of SR147778 (0.3-3 mg/kg, i.p.) suppressed the 'alcohol deprivation effect', i.e. the extra-intake of alcohol occurring after a period of alcohol abstinence. In Experiment 4, an acute administration of SR147778 (0.3-3 mg/kg, i.p.) specifically suppressed the extinction responding for alcohol, i.e. the maximal number of lever responses reached in the absence of alcohol in rats trained to lever-press for alcohol (measure of the motivational properties of alcohol). In Experiment 5, the combination of 3 mg/kg of SR147778 (i.p.) and 0.5 g/kg of alcohol (i.p.), a dose comparable with those usually consumed by sP rats in each drinking binge, failed to induce any conditioned taste aversion. CONCLUSION: Taken together, these results extend to SR147778 the anti-alcohol profile of the prototype cannabinoid CB(1) receptor antagonist, rimonabant (SR141716), and strengthen the hypothesis that the cannabinoid CB(1) receptor is part of the neural substrate mediating alcohol intake and the motivational properties of alcohol.
机译:目的:本研究调查了新合成的大麻素CB(1)受体拮抗剂SR147778对选择性饲养撒丁岛酒精偏爱(sP)大鼠的酒精摄入量和酒精动机的影响。方法和结果:在实验1中,重复给药SR147778(0.3-3 mg / kg每天两次,腹膜内)特别抑制了暴露于两瓶“酒精与水”选择的未经酒精喂养的大鼠的饮酒行为每天24小时。在实验2中,SR147778(2.5-10 mg / kg,i.p.)的急性给药在每天两次的双瓶选择方案下每天4小时给有酒精和水的有酒精经验的大鼠中特别减少了酒精的摄入。在实验3中,SR147778(0.3-3 mg / kg,腹膜内)的急性给药抑制了“酒精剥夺效应”,即戒酒一段时间后过量摄入酒精。在实验4中,SR147778(0.3-3 mg / kg,ip)的急性给药特别抑制了对酒精的灭绝反应,即,在接受酒精杠杆训练的大鼠中,在无酒精的情况下达到的最大杠杆反应数(酒精的刺激性指标)。在实验5中,3 mg / kg SR147778(i.p.)和0.5 g / kg酒精(i.p.)的组合(与每次饮酒狂欢中sP大鼠通常消耗的剂量相当)未能引起任何条件性味觉厌恶。结论:综上所述,这些结果扩展到SR147778原型大麻素CB(1)受体拮抗剂利莫那班(SR141716)的抗酒精性,并强化了大麻素CB(1)受体是神经基质介导的一部分的假设。酒精摄入量和酒精的动机特性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号